As an example, the PSMA PET/CT could predict progression-free survival in localized PCa (Roberts et al., 2020) and could even guide the use of salvage treatments such as radiotherapy (Emmett et al., 2020). This evidence concerns the gene FOLH1 and posterior cortical atrophy.